Highly Active Antiretroviral Therapy Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Examining Benefits of HAART Continuation in Postpartum Women
Condition: HIV InfectionIntervention: Drug: Highly active antiretroviral therapy (HAART)Sponsors: International Maternal Pediatric Adolescent AIDS Clinical Trials Group; National Institute of Allergy and Infectious Diseases (NIAID); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)Active, not recruiting - verified March 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 7, 2009 Category: Research Source Type: clinical trials

Nevirapine Clearance After Short-term Highly Active Antiretroviral Therapy (HAART) for Prevention of Mother to Child Transmission of HIV (PMTCT)
Conditions: NVP Plasma Level; NVP Related Mutation; 3TC Related MutationIntervention: Drug: AZT/3TC 2 weeks after deliverySponsors: Thai Red Cross AIDS Research Centre; Chulalongkorn University; Queen Savang Vadhana Memorial Hospital, ThailandRecruiting - verified September 2009 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 30, 2009 Category: Research Source Type: clinical trials

A Pilot Study Of the Effects of Highly Active Antiretroviral Therapy on Kaposi's Sarcoma in Zimbabwe
Condition: AIDS-related Kaposi's SarcomaInterventions: Drug: abacavir/3TC/zidovudine; Drug: abacavir /3TC plus ritonavir boosted lopinavirSponsors: Parirenyatwa Hospital; University of Colorado, Denver; GlaxoSmithKline; AbbottCompleted - verified October 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 2, 2009 Category: Research Source Type: clinical trials

Comparative Study of Three NNRTI-Sparing HAART Regimens
Condition: HIV InfectionInterventions: Drug: Emtricitabine/tenofovir disoproxil fumarate; Drug: Raltegravir; Drug: Darunavir; Drug: Ritonavir; Drug: AtazanavirSponsors: AIDS Clinical Trials Group; National Institute of Allergy and Infectious Diseases (NIAID); Bristol-Myers Squibb; Gilead Sciences; Merck Sharp & Dohme Corp.; Tibotec Therapeutics, a Division of Ortho Biotech Products, L.P., USACompleted - verified September 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 18, 2008 Category: Research Source Type: clinical trials

Antiretroviral Therapy for Acute HIV Infection
Condition: Acute HIV InfectionInterventions: Drug: HAART; Drug: Mega-HAARTSponsors: South East Asia Research Collaboration with Hawaii; Thai Red Cross AIDS Research Centre; Pfizer; Gilead Sciences; Merck Sharp & Dohme Corp.Recruiting - verified November 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 21, 2008 Category: Research Source Type: clinical trials